These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 17655895)

  • 21. [Influenza type A (H5N1) virus infection].
    Engin A
    Mikrobiyol Bul; 2007 Jul; 41(3):485-94. PubMed ID: 17933264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza.
    Hill AW; Guralnick RP; Wilson MJ; Habib F; Janies D
    Infect Genet Evol; 2009 Mar; 9(2):169-78. PubMed ID: 19022400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modifying clinical practices to manage influenza in children effectively.
    Glezen WP
    Pediatr Infect Dis J; 2008 Aug; 27(8):738-43. PubMed ID: 18664986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective measures and human antibody response during an avian influenza H7N3 outbreak in poultry in British Columbia, Canada.
    Skowronski DM; Li Y; Tweed SA; Tam TW; Petric M; David ST; Marra F; Bastien N; Lee SW; Krajden M; Brunham RC
    CMAJ; 2007 Jan; 176(1):47-53. PubMed ID: 17200390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The new pandemic influenza A/H1N1. Antiviral agents for the initial stage--vaccine reduces the effects in the long run].
    Uhnoo I; Bergquist C
    Lakartidningen; 2009 Jul 8-21; 106(28-29):1814-9. PubMed ID: 19685621
    [No Abstract]   [Full Text] [Related]  

  • 26. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.
    Du QS; Wang SQ; Chou KC
    Biochem Biophys Res Commun; 2007 Oct; 362(2):525-31. PubMed ID: 17707775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2008 Jul; 34(ACS-3):1-46. PubMed ID: 18802991
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.
    Sugaya N; Tamura D; Yamazaki M; Ichikawa M; Kawakami C; Kawaoka Y; Mitamura K
    Clin Infect Dis; 2008 Aug; 47(3):339-45. PubMed ID: 18582202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tamiflu resistance].
    Nau JY
    Rev Med Suisse; 2006 Dec; 2(91):2886. PubMed ID: 17236332
    [No Abstract]   [Full Text] [Related]  

  • 30. Possible case scenarios and logistic issues in H5N1 pandemic.
    Tsang KW; Shim YS; Wong TK; Liam CK; Eng P; Lam WK; Seto WH
    Respirology; 2006 Sep; 11(5):520-2. PubMed ID: 16916322
    [No Abstract]   [Full Text] [Related]  

  • 31. Oseltamivir: new indication. Prevention of influenza in at-risk children: vaccination is best.
    Prescrire Int; 2007 Feb; 16(87):9-11. PubMed ID: 17323516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza: evolving strategies in treatment and prevention.
    Lynch JP; Walsh EE
    Semin Respir Crit Care Med; 2007 Apr; 28(2):144-58. PubMed ID: 17458769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [When the Avian virus (H5N1) become resistant to Tamiflu and the resulting consequences].
    Nau JY
    Rev Med Suisse; 2006 Jan; 2(48):171. PubMed ID: 16463806
    [No Abstract]   [Full Text] [Related]  

  • 34. Antiviral drugs for influenza.
    Med Lett Drugs Ther; 2008 Dec 15-29; 50(1301-1302):98-9, 104; quiz p following 104. PubMed ID: 19078865
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antiviral agents in influenza--current recommendations. Anti-influenza agents are not a substitution for but a complement to vaccination].
    Uhnoo I; Linde A
    Lakartidningen; 2005 Dec 5-11; 102(49):3802-3, 3805-6, 3808. PubMed ID: 16408704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the effectiveness of Zanamivir and Oseltamivir against influenza A/H1N1, A/H3N2, and B.
    Kawai N; Ikematsu H; Iwaki N; Maeda T; Kawashima T; Hirotsu N; Kashiwagi S
    Clin Infect Dis; 2009 Apr; 48(7):996-7. PubMed ID: 19260819
    [No Abstract]   [Full Text] [Related]  

  • 37. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of Tamiflu under pandemic conditions].
    Nau JY
    Rev Med Suisse; 2009 Jul; 5(211):1532. PubMed ID: 19694366
    [No Abstract]   [Full Text] [Related]  

  • 39. Basic rules of influenza: how to combat the H1N1 influenza (swine flu) virus.
    Temte JL
    Am Fam Physician; 2009 Jun; 79(11):938-9. PubMed ID: 19514689
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiviral treatment and prophylaxis of influenza virus in children.
    Nayak JL; Treanor JJ
    Pediatr Ann; 2009 Dec; 38(12):667-74. PubMed ID: 20000234
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.